A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

A weight loss pill called orforglipron has had some successful results from the human trial stage, so when could we see it on the NHS?

In the U.S. where adoption is highest, fewer than 1 in 10 adults are on a GLP-1 drug, despite nearly three-quarters being overweight or obese. Globally access is even more limited, held back by high ...

A trial of 3,127 patients who took a daily pill for 72 weeks saw an average weight loss per person of 12.3kg. While injectable obesity drugs are peptides designed to replicate the appetite-controlling ...